StockData
NeoGenomics Inc logo

NeoGenomics Inc (NEO) stock

NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3024% below fair value
$14.82−0.27 (-1.79%)

Close on Nov 20, 2026Market cap $1.92BP/E –Yield –

NeoGenomics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

NeoGenomics's shares outstanding was 129M at Sep 30, 2026. For fiscal 2025 it was 128M, up 1.1% from the year before. Over ten years it grew 7.8% a year on average. The highest annual figure on record is 128M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025128M+1.1%
FY2024Dec 31, 2024127M+0.9%
FY2023Dec 31, 2023126M+1.0%
FY2022Dec 31, 2022124M+3.5%
FY2021Dec 31, 2021120M+7.3%
FY2020Dec 31, 2020112M+7.9%
FY2019Dec 31, 2019104M+13.2%
FY2018Dec 31, 201892M+15.3%
FY2017Dec 31, 201779M+2.4%
FY2016Dec 31, 201678M+28.1%
FY2015Dec 31, 201561M+8.1%
FY2014Dec 31, 201456M+6.1%
FY2013Dec 31, 201353M+8.3%
FY2012Dec 31, 201249M+13.9%
FY2011Dec 31, 201143M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026129M+0.1%
Q2 FY2026Jun 30, 2026131M+2.3%
Q1 FY2026Mar 31, 2026129M+1.4%
Q4 FY2025Dec 31, 2025129M+1.2%
Q3 FY2025Sep 30, 2025128M+1.2%
Q2 FY2025Jun 30, 2025128M+1.2%
Q1 FY2025Mar 31, 2025127M+1.0%
Q4 FY2024Dec 31, 2024127M+1.0%
Q3 FY2024Sep 30, 2024127M+1.0%
Q2 FY2024Jun 30, 2024126M+0.8%
Q1 FY2024Mar 31, 2024126M+0.9%
Q4 FY2023Dec 31, 2023126M+1.0%
Q3 FY2023Sep 30, 2023126M+1.0%
Q2 FY2023Jun 30, 2023125M+1.0%
Q1 FY2023Mar 31, 2023125M+1.1%
Q4 FY2022Dec 31, 2022125M+7.7%
Q3 FY2022Sep 30, 2022124M+1.5%
Q2 FY2022Jun 30, 2022124M-5.5%
Q1 FY2022Mar 31, 2022124M+6.4%
Q4 FY2021Dec 31, 2021116M-6.9%
Q3 FY2021Sep 30, 2021123M+2.8%
Q2 FY2021Jun 30, 2021131M+21.6%
Q1 FY2021Mar 31, 2021116M+11.2%
Q4 FY2020Dec 31, 2020124M+15.3%
Q3 FY2020Sep 30, 2020119M+10.5%
Q2 FY2020Jun 30, 2020108M+5.4%
Q1 FY2020Mar 31, 2020104M+10.3%
Q4 FY2019Dec 31, 2019108M+11.3%
Q3 FY2019Sep 30, 2019108M+18.7%
Q2 FY2019Jun 30, 2019102M+13.5%
Q1 FY2019Mar 31, 201995M+17.7%
Q4 FY2018Dec 31, 201897M+9.3%
Q3 FY2018Sep 30, 201891M+14.2%
Q2 FY2018Jun 30, 201890M+13.5%
Q1 FY2018Mar 31, 201881M+2.4%
Q4 FY2017Dec 31, 201789M+12.9%
Q3 FY2017Sep 30, 201780M–
Q2 FY2017Jun 30, 201779M–
Q1 FY2017Mar 31, 201779M–
Q4 FY2016Dec 31, 201678M–

More NeoGenomics figures

See a number that looks wrong?